Read More 1 minute read Funding News News Therapeutics ADDF Invests $5M in Coya Therapeutics for FTD Phase 2 Trial Key Highlights ADDF purchases 603,136 shares of Coya Therapeutics at $8.29 per share. Investment to fund Phase 2… byChris-Anne RoqueMay 22, 2024
Read More 1 minute read M&A News News IVI RMA Expands with Eugin Group’s North American Fertility Operations Key Highlights IVI RMA acquires Boston IVF and TRIO, enhancing its market presence in North America. Over 600… byChris-Anne RoqueFebruary 12, 2024